High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

This grant supports innovative research at the intersection of HIV and substance use, aiming to open new areas of HIV/AIDS research and new prevention, treatment, or cure avenues for people who use drugs. It funds projects across basic science, clinical, and implementation research and is open to individual researchers and research teams.

Amount: up to $1.5M
Type: Grant

Key facts

Key facts for High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Amount	up to $1.5M
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	EdTech · HealthTech
Deadline	Closes 05 Mar 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked yesterday

86 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026